According to new data published in Blood, patients with multiple myeloma (MM) who are hospitalized for COVID-19 infection face higher mortality compared with patients without MM, with age, disease status, and renal involvement serving as predictors of worse outcomes. MM is a hematological cancer of the plasma cells, particularly within bone marrow. Immunosuppression often presents … Continue reading Higher Rates of COVID-19 Mortality for Patients with Multiple Myeloma